Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Hestetandklinikken ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   2.1% 1.6% 1.5% 1.5% 1.9% 1.7% 12.0% 12.0%   Credit score (0-100)   70 77 76 75 69 72 20 20   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   0.2 9.1 23.7 20.6 1.7 9.5 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,356 4,534 5,825 7,579 8,733 8,874 0.0 0.0   EBITDA   864 1,481 2,211 2,600 3,292 3,359 0.0 0.0   EBIT   759 1,341 2,061 2,383 3,008 3,238 0.0 0.0   Pre-tax profit (PTP)   756.2 1,327.1 2,524.3 2,593.3 2,976.2 3,351.7 0.0 0.0   Net earnings   588.2 1,034.1 2,072.3 2,064.2 2,316.9 2,639.5 0.0 0.0   Pre-tax profit without non-rec. items   756 1,327 2,524 2,593 2,976 3,352 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   449 928 1,019 539 286 164 0.0 0.0   Shareholders equity total   813 1,259 2,331 2,164 2,417 3,556 1,497 1,497   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,775 2,696 4,795 3,914 4,178 5,582 1,497 1,497   Net Debt   -1,085 -1,279 -2,501 -2,519 -3,025 -4,245 -1,497 -1,497     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,356 4,534 5,825 7,579 8,733 8,874 0.0 0.0   Gross profit growth   89.6% 35.1% 28.5% 30.1% 15.2% 1.6% -100.0% 0.0%   Employees   6 6 7 7 7 7 0 0   Employee growth %   200.0% 0.0% 16.7% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,775 2,696 4,795 3,914 4,178 5,582 1,497 1,497   Balance sheet change%   46.0% 51.9% 77.9% -18.4% 6.7% 33.6% -73.2% 0.0%   Added value   863.8 1,481.4 2,210.9 2,599.6 3,224.6 3,359.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -54 338 -58 -697 -536 -243 -164 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   22.6% 29.6% 35.4% 31.4% 34.4% 36.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   50.8% 60.0% 67.7% 60.5% 75.0% 69.1% 0.0% 0.0%   ROI %   97.7% 122.0% 125.8% 108.1% 131.4% 112.8% 0.0% 0.0%   ROE %   77.4% 99.8% 115.4% 91.8% 101.1% 88.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   45.8% 46.7% 48.6% 55.3% 57.8% 63.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -125.6% -86.3% -113.1% -96.9% -91.9% -126.4% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.3 1.2 1.5 2.0 2.4 2.8 0.0 0.0   Current Ratio   1.4 1.3 1.5 2.1 2.5 2.9 0.0 0.0   Cash and cash equivalent   1,085.2 1,278.6 2,501.3 2,518.7 3,024.5 4,245.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   382.9 399.0 1,131.9 1,649.3 2,314.5 3,444.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   144 247 316 371 461 480 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   144 247 316 371 470 480 0 0   EBIT / employee   126 223 294 340 430 463 0 0   Net earnings / employee   98 172 296 295 331 377 0 0